Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 84 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 85 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 91 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 94 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 95 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 97 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 97 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 99 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 100 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 102 | Counts | 60-64 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 102 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 103 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 104 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 104 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 105 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 106 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 107 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 107 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 107 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 107 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 108 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 108 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 110 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 110 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 111 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 111 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 111 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 112 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 113 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 113 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 114 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 114 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 115 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 115 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 115 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 116 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 117 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 118 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 119 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 119 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 120 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 120 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 121 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 122 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 122 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 123 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 123 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 124 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 126 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 127 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 128 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 128 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 129 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 129 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 129 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 130 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 130 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 131 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 131 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 131 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 131 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 132 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 132 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 134 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 135 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 135 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 136 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 136 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 137 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 137 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 137 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 138 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 138 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 139 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 139 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 139 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 142 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 142 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 142 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 142 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 142 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 142 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 143 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 144 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 144 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 144 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 145 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 146 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 147 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 147 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 147 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 147 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 147 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 148 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 148 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 149 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 150 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 150 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 151 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 151 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 152 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 153 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 154 | Counts | 55-59 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 154 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 154 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 155 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 155 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 157 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 157 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 158 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 158 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 158 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 158 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 158 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 158 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 159 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 159 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 159 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 159 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 160 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 161 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 161 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 161 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 165 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 167 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 168 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 169 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 169 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 169 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 170 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 171 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 171 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 171 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 172 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 172 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 172 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 172 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 173 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 174 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 177 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 180 | Counts | 70-74 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 181 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 184 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 184 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 185 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 185 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 186 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 186 | Counts | 65-69 | Female | Former | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 187 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 189 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 189 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 190 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 191 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 192 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 193 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 194 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 194 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 196 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 197 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 198 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 199 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 200 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 200 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 201 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 203 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 204 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 207 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 210 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 212 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 213 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 213 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 217 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 217 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 218 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 226 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 226 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 228 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 229 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 230 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 230 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 233 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 235 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 235 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 240 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 241 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 243 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 244 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 244 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 245 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 246 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 249 | Counts | 65-69 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 256 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 257 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 260 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 261 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 265 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 266 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 269 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 270 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | dihydro-3-coumaric acid | 270 | Counts | 55-59 | Male | Former | - |
Return to search page